OBJECTIVE: Disparities in HIV infection, with females having higher rates of HIV infection than males, have been noted among persons who inject drugs (PWID) in many countries. We examined male/female HIV disparities among PWID in Central Asia and compared these disparities with patterns worldwide. METHODS: A systematic review and meta-analyses were conducted for studies reporting HIV prevalence by gender among PWID. To be included in the analyses, reports had to contain (1) samples of PWID from Central Asia, (2) HIV data based on laboratory testing, (3) HIV prevalence reported for males and females, and (4) samples that were not recruited on the basis of HIV status. RESULTS: Data were abstracted from 11 studies in 5 countries in Central Asia: China, Kazakhstan, Russia, Tajikistan, and Uzbekistan; the total sample size was 12,225. The mean weighted OR for HIV prevalence among females to males was 0.913 (95% CI 0.07, 1.26), with high heterogeneity among studies (I(2)=70.0%) and a possible publication bias among studies with small sample sizes (Eggers test=-1.81, 95% CI -5.18, 0.54). CONCLUSIONS: The non-significant higher HIV prevalence among male PWID in Central Asia contrasts with the worldwide findings which show slightly higher HIV prevalence among female PWID. This may reflect the relative recency of the HIV epidemics in Central Asia. The findings also suggest there may be factors that protect female PWID from HIV in some settings. Further examination of transmission dynamics in Central Asia is necessary to better understand the HIV epidemic among PWID.
OBJECTIVE: Disparities in HIV infection, with females having higher rates of HIV infection than males, have been noted among persons who inject drugs (PWID) in many countries. We examined male/female HIV disparities among PWID in Central Asia and compared these disparities with patterns worldwide. METHODS: A systematic review and meta-analyses were conducted for studies reporting HIV prevalence by gender among PWID. To be included in the analyses, reports had to contain (1) samples of PWID from Central Asia, (2) HIV data based on laboratory testing, (3) HIV prevalence reported for males and females, and (4) samples that were not recruited on the basis of HIV status. RESULTS: Data were abstracted from 11 studies in 5 countries in Central Asia: China, Kazakhstan, Russia, Tajikistan, and Uzbekistan; the total sample size was 12,225. The mean weighted OR for HIV prevalence among females to males was 0.913 (95% CI 0.07, 1.26), with high heterogeneity among studies (I(2)=70.0%) and a possible publication bias among studies with small sample sizes (Eggers test=-1.81, 95% CI -5.18, 0.54). CONCLUSIONS: The non-significant higher HIV prevalence among male PWID in Central Asia contrasts with the worldwide findings which show slightly higher HIV prevalence among female PWID. This may reflect the relative recency of the HIV epidemics in Central Asia. The findings also suggest there may be factors that protect female PWID from HIV in some settings. Further examination of transmission dynamics in Central Asia is necessary to better understand the HIV epidemic among PWID.
Authors: Julie A Stachowiak; Farida K Tishkova; Steffanie A Strathdee; Mark A Stibich; Alisher Latypov; Vladimir Mogilnii; Chris Beyrer Journal: Drug Alcohol Depend Date: 2006-04 Impact factor: 4.492
Authors: Andrei P Kozlov; Alla V Shaboltas; Olga V Toussova; Sergei V Verevochkin; Benoit R Masse; Tom Perdue; Geetha Beauchamp; Wayne Sheldon; William C Miller; Rober Heimer; Robert W Ryder; Irving F Hoffman Journal: AIDS Date: 2006-04-04 Impact factor: 4.177
Authors: K F Corsi; S Dvoryak; C Garver-Apgar; J M Davis; J T Brewster; O Lisovska; R E Booth Journal: Drug Alcohol Depend Date: 2014-02-20 Impact factor: 4.492
Authors: Janni Leung; Amy Peacock; Samantha Colledge; Jason Grebely; Evan B Cunningham; Matthew Hickman; Peter Vickerman; Jack Stone; Adam Trickey; Kostyantyn Dumchev; Michael Lynskey; Lindsey Hines; Paul Griffiths; Richard P Mattick; Louisa Degenhardt; Sarah Larney Journal: J Infect Dis Date: 2019-06-05 Impact factor: 5.226
Authors: Horacio Ruiseñor-Escudero; Alexander Vu; Andrea L Wirtz; Itziar Familiar-Lopez; Mark Berry; Iliassou Mfochive; Cyrus Engineer; Ahmad Farhad; Senop Tschakarjan; Ernst Wisse; Feda M Paikan; Gilbert Burnham Journal: Harm Reduct J Date: 2015-09-04